Código QR (código de barras bidimensional)

The origins of Novo Nordisk and Novartis products: piloting a framework to identify the public contributions

Background The objective of this case study is to pilot a framework of public contributions examining the origins of products from two major European pharmaceutical companies, Novartis and Novo Nordisk, that received approval from the European Medicines Agency (EMA) between January 2014 and May 2024...

ver descrição completa

Na minha lista:
Principais autores: Daniel Fabian, Ozren Sehic, Claudia Wild
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis Group 2025-12-01
coleção:Journal of Pharmaceutical Policy and Practice
Assuntos:
Public contributions
Novo Nordisk
Novartis
product origin
public return on public investments (PRoPI)
transparency
Acesso em linha:https://www.tandfonline.com/doi/10.1080/20523211.2025.2534919
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados